Business · 19/11/1998Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 61 ANDA's from Danbury Pharmacal, Inc.
Summary
The FDA has withdrawn approval of 61 abbreviated new drug applications (ANDA's) following a request from Danbury Pharmacal, Inc., which notified the agency that the corresponding drug products are no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →